Loading...

Shanghai's MicroPort to pay USD190 mn for LivaNova's cardiac business

 26-Nov-17, LivaNova 

The UK's LivaNova and MicroPort of China have entered into a binding Letter of Intent for the sale of LivaNova’s Cardiac Rhythm Management (CRM) business to MicroPort for USD190 million in cash.

Shanghai's MicroPort to pay USD190 mn for LivaNovas cardiac business (c) Cardiac Rhythm News

Image: LivaNova; MicroPort

The CRM business generated approximately USD249 mn net sales in 2016 and has 900 employees with operations in: Clamart, France; Saluggia, Italy; and Santo Domingo, Dominican Republic. 

In 2014, LivaNova (formerly Sorin Group) and MicroPort founded a China-based joint venture to market CRM devices, including implantable pacemakers, defibrillators and cardiac resynchronization devices.

In Sep-17, the  China FDA approved its Rega pacemaker family, the smallest sized pacemakers available on the Chinese market.

 Read the full article 

 Healthcare insights 

Share